Fairway Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Fairway Wealth's VRTX Position: Q2 2026 in Review
Fairway Wealth opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 13 shares worth $6.46K. The stake represents ﹤0.01% of the portfolio and ranks #203 among its holdings. This is a return to the name: Fairway Wealth previously reported a position in VRTX as recently as Q4 2024.
Fairway Wealth first reported a position in VRTX in Q2 2024 and has held it in 3 quarters since. The position peaked at $11.2K in Q2 2024. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Fairway Wealth held 13 shares of Vertex Pharmaceuticals worth $6.46K as of Q2 2026.
- Vertex Pharmaceuticals was a new Fairway Wealth position in Q2 2026.
- Vertex Pharmaceuticals made up ﹤0.01% of Fairway Wealth's portfolio in Q2 2026, its #203 holding.
- Fairway Wealth first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 3 quarters since.
- Fairway Wealth's Vertex Pharmaceuticals position peaked at $11.2K in Q2 2024.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Fairway Wealth's 13F filing for Q2 2026, filed 24 Jul 2026.